ZBIO · US market

Zenas Biopharma, Inc.

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$1.82bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-3.76×
Latest-quarter run-rate P/E-4.08×
Trailing P/S1821.04×
Latest-quarter run-rate P/S455.26×

Calculation inputs

Trailing earnings
-US$484.38m
Latest-quarter run-rate earnings
-US$445.82m
Latest fiscal-year earnings
-US$377.74m
Trailing revenue
US$1.00m
Latest-quarter run-rate revenue
US$4.00m
Latest fiscal-year revenue
US$10.00m

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

  • FMED · Fidelity Disruptive Medicine ETF0.44% weight · Holdings dated 31 May 2026
  • XBI · State Street SPDR S&P Biotech ETF0.40% weight · Holdings dated 21 August 2026
  • QUAZX · AB Small Cap Growth Portfolio Class Z0.26% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • FSCRX · Fidelity Small Cap Discovery Fund0.23% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • FJACX · Fidelity Series Small Cap Discovery Fund0.22% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • IWC · iShares Micro-Cap ETF0.21% weight · Holdings dated 21 August 2026
  • FSSLX · Fidelity Series Small Cap Core Fund0.19% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • FSOPX · Fidelity Series Small Cap Opportunities Fund0.16% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • FSSZX · Fidelity Advisor Stock Selector Small Cap Fund Class Z0.15% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • PGRTX · Principal SmallCap Growth Fund I Institutional Class0.09% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.